TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin

X F Zheng1, D Florentino, J Chen

  • 1Howard Hughes Medical Institute Department of Chemistry, Harvard University Cambridge, Massachusetts 02138, USA.

Cell
|July 14, 1995
PubMed

Insights

The rapamycin-sensitive pathway, involving TOR1 and TOR2 proteins, regulates cell cycle progression. Kinase activity is crucial for G1 function, with rapamycin selectively inhibiting this process.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • The rapamycin-sensitive pathway is crucial for transmitting mitogenic signals to the cell cycle machinery, specifically for G1 phase progression.
  • Genetic studies in yeast identified TOR1 and TOR2 as key genes in this pathway, hypothesized to be novel phosphatidylinositol kinases.

Purpose of the Study:

  • To investigate the functional requirement of the kinase domain in TOR1 and TOR2 proteins for their roles in G1 cell cycle progression.
  • To elucidate the mechanism by which FKBP12-rapamycin affects TOR protein function, particularly concerning G1 phase and essential cellular processes.

Main Methods:

  • Genetic analysis of yeast strains with mutations in TOR1 and TOR2 genes.
  • Assessment of cell cycle progression (G1) and cell growth under various conditions, including rapamycin treatment.
  • Functional characterization of the kinase and FKBP12-rapamycin-binding domains of TOR proteins.

Main Results:

  • An intact kinase domain is essential for the G1 cell cycle functions of both TOR1 and TOR2 proteins.
  • Overexpression of a mutated TOR1 protein (affecting the FKBP12-rapamycin-binding domain) inhibited yeast cell growth.
  • The essential function of TOR2 requires an intact kinase domain, but this function is not sensitive to rapamycin.
  • While the G1 function of both TOR proteins is rapamycin-sensitive, the essential function of TOR2 is not.

Conclusions:

  • The kinase activity of TOR proteins is indispensable for their G1 cell cycle functions.
  • FKBP12-rapamycin does not broadly inhibit TOR kinase activity but likely interferes selectively with effector interactions or phosphorylation.
  • This selective interference suggests a nuanced regulatory mechanism of TOR proteins in cell cycle control and essential cellular processes.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K